Ramosetron is a serotonin 5-HT3 receptor antagonist commonly employed to treat nausea and vomiting, in addition to certain diarrheal conditions. It is believed to have higher potency and longer antiemetic action than other 1st generation 5-HT3 antagonists such as ondansetron. Currently, ramosetron is only approved for use Japan and in certain Southeast Asian...
For the treatment of nausea and vomiting and diarrhea-predominant irritable bowel syndrome in males.
Seoul National University Bundang Hospital, Seongnam Si, Gyeonggi Do, Korea, Republic of
Catholic Blood & Marrow Transplantation Center, Seoul St Mary's Hospital, the Catholic University of Korea, Seoul, Korea, Republic of
Seoul National University Hospital, Seoul, Korea, Republic of
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Hyo Jung Kim, Anyang, Gyeonggi-do, Korea, Republic of
Incheon St. Mary's hospital, Incheon, Korea, Republic of
School of Medicine, Kyung Hee University, Seoul, Korea, Republic of
Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
Joint Reconstruction Center, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.